NJ Retina is a clinical research site located in Toms River, New Jersey, United States 08755.
Crixeo Health Trust Score: 71/100 (FAIR). This profile has not yet been claimed by the site owner.
NJ Retina has participated in 7 clinical trials with 4 currently active.
Therapeutic areas: Age-Related Macular Degeneration, Geographic Atrophy, Macular Degeneration.
Sponsors: Notal Vision Inc., Astellas Pharma Global Development, Inc., Apellis Pharmaceuticals, Inc..
Trust Score: 71/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
NJ Retina has a Crixeo Trust Score of 71/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
NJ Retina has 7 clinical trials on record, with 4 currently active. Their work covers Age-Related Macular Degeneration, Geographic Atrophy, Macular Degeneration.
Yes — NJ Retina holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.